OnMed's 'Clinic-in-a-Box' Aims to Heal America's Healthcare Deserts

NEW YORK, NY – February 06, 2026 – Healthcare technology firm OnMed has received a significant accolade for its innovative approach to medical access, with its CareStation being named the 2026 Impact Product of the Year by the Impact One Awards. The company, a proponent of tech-enabled hybrid healthcare, was reportedly selected from a field of over 11,000 contenders in a year-long evaluation process focused on products making a measurable societal difference.

The recognition highlights a growing consensus around the need for disruptive solutions to America's deepening healthcare crisis. OnMed’s flagship product, the CareStation, is a self-contained, 8×10 foot “Clinic-in-a-Box” designed to deliver comprehensive medical services in locations where traditional healthcare is scarce or non-existent. By blending the immediacy of virtual care with the thoroughness of an in-person visit, the company aims to bridge a critical gap for millions.

"This recognition validates what we see every day in communities across America: when you remove barriers to healthcare access, you transform lives," said Karthik Ganesh, CEO of OnMed, in a statement. "The CareStation isn’t simply a product. It’s a lifeline. It’s proof that access to quality healthcare shouldn’t depend on your zip code or your proximity to a major medical center."

Addressing a National Crisis

The problem OnMed seeks to solve is one of staggering scale and complexity. According to the Association of American Medical Colleges (AAMC), the United States is facing a projected shortage of up to 124,000 physicians by 2034. This deficit disproportionately affects rural and underserved urban areas, creating vast “healthcare deserts” where basic medical services are out of reach.

Data from the Health Resources and Services Administration (HRSA) confirms this reality, designating thousands of regions as Health Professional Shortage Areas (HPSAs). For the 120 million Americans that OnMed says lack adequate healthcare access, this often means delayed diagnoses, poorly managed chronic conditions, and an over-reliance on hospital emergency departments for non-emergency issues.

This trend carries a hefty price tag. Health policy research has consistently shown that a significant percentage of emergency room visits could be handled in lower-cost primary care settings, contributing to what Ganesh describes as "$168 billion wasted treating avoidable and non-emergency cases in the Emergency Department." The economic fallout extends to the workforce, with an estimated $575 billion lost annually due to health-related absenteeism.

Inside the 'Clinic-in-a-Box'

The OnMed CareStation is engineered to be a frontline defense against these challenges. Each unit functions as a miniature clinic, enabling a patient to connect with a live clinician for a one-on-one consultation. More than just a video call, the station is equipped with a suite of diagnostic tools that allow for real-time monitoring of vitals and advanced scans, enabling clinicians to perform a comprehensive examination remotely.

This hybrid model—combining human interaction with AI-powered technology—is designed for immediate and definitive care. According to company-provided data, the approach is proving effective: 82% of patients are reportedly treated on-site without needing a referral or escalation to another facility. Furthermore, 58% of users reported that they would have otherwise gone to an emergency room or urgent care center, suggesting the CareStation is successfully diverting patients from more expensive and overburdened points of care.

The model offers a compelling value proposition for a wide range of stakeholders. For employers and educational institutions, on-site access can reduce absenteeism and increase productivity. For insurers and health systems, it promises significant cost savings through ER avoidance and better management of patient populations. For governments, it offers a scalable solution to close provider gaps in rural and underserved communities.

Navigating a Competitive and Evolving Landscape

OnMed is a prominent player in a rapidly evolving health-tech landscape, but it is not alone in its mission to expand healthcare access. The market includes telehealth giants offering purely virtual consultations, as well as retail clinics within pharmacies that provide convenient in-person care for minor ailments. OnMed’s key differentiator is its physical, diagnostic-equipped kiosk that combines the strengths of both models—the scalability of virtual care with the data-rich environment of a clinical setting.

The Impact Product of the Year award joins a growing list of accolades for the company, including being named one of TIME’s Best Inventions of 2025 and receiving a CES 2025 Picks Award. These recognitions from the technology and innovation sectors underscore the disruptive potential of its model.

The Path to Scale: A Public Future?

With CareStations already deployed across seven states and Puerto Rico, OnMed has its sights set on a far more ambitious future: a national grid of its clinics capable of serving 200 million people annually. This vision of creating a new layer of healthcare infrastructure requires significant capital, and the company has signaled its intended path forward.

OnMed recently announced that it has entered into a non-binding letter of intent for a business combination with Berto Acquisition Corp. (NASDAQ: TACO), a publicly traded special purpose acquisition company, or SPAC. A SPAC merger offers a faster route to the public markets than a traditional initial public offering (IPO), providing a company with access to public capital to fund growth and expansion.

While a non-binding letter of intent is only the first step in a complex process that requires due diligence and regulatory approval, it marks a clear strategic move. If the merger is completed, the infusion of capital could be the catalyst OnMed needs to accelerate the deployment of its CareStations nationwide. The success of this financial maneuver may ultimately determine whether the "Clinic-in-a-Box" can move from a promising innovation to a fundamental and transformative part of America's healthcare system.